• Journey Medical Corp DERM.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -53 cents. The mean expectation of four analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -29 cents to -19 cents per share.

• Revenue rose 0.8% to $13.14 million from a year ago; analysts expected $12.05 million.

• Journey Medical Corp's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $4.07 million.

• Journey Medical Corp shares had risen by 7.1% this quarter and gained 61.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 137.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Journey Medical Corp is $9.75

This summary was machine generated from LSEG data May 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)